I'm very confident management will soon appreciate the need to examine other indications and the SP will rise accordingly.
Look at other companies with preliminary research in diseases with large TAMs (e.g. AGN - stroke).
They also haven't announced IXC'S involvement in the space research study.
- Forums
- ASX - By Stock
- Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021
I'm very confident management will soon appreciate the need to...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.411M |
Open | High | Low | Value | Volume |
7.5¢ | 7.5¢ | 7.2¢ | $8.821K | 118.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49983 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 112842 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49983 | 0.072 |
1 | 50000 | 0.068 |
1 | 84879 | 0.067 |
1 | 100000 | 0.066 |
1 | 100000 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 112842 | 1 |
0.080 | 5000 | 1 |
0.083 | 40000 | 1 |
0.085 | 8805 | 1 |
0.090 | 126146 | 1 |
Last trade - 13.28pm 18/09/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |